Kenneth G. Krul

• Advanced Drug Delivery
• Advances in cancer therapy
• Biopharmaceutical industry in transition
• Congestive heart failure
• Critical survival factors for drug discovery programs
• Current developments in immunotherapy markets and technology (A Kalorama Information market intelligence report)
• Diabetes and diabetic complications in key world markets
• Drug-eluting stents
• Emerging cancer therapies
• Molecular diagnostics for inherited disease testing
• Neurologic cancers
• On the nature of apo-ascorbate oxidase, its reconstitution and holoenzyme